Value Assessment and Health Outcomes Research Faculty Starter Grant

Funder: Pharmaceutical Research And Manufacturers Of America Fnd Inc (PhRMA)

The Value Assessment and Health Outcomes Research Faculty Starter Grant, offered by the PhRMA Foundation, supports emerging researchers at U.S. universities. With a funding of $100,000 for one year, it aims to advance studies on the effectiveness and value of healthcare interventions. The grant promotes innovative research in areas such as clinical outcomes, health equity, and patient engagement, ensuring that diverse perspectives are included in the evaluation of healthcare solutions.

The Foundation catalyzes the careers of promising researchers through competitive, peer-reviewed grants and fellowships in the fields of drug delivery, drug discovery, translational medicine, and value assessment and health outcomes research.
Value Assessment and Health Outcomes Research Faculty Starter Grant
The PhRMA Foundation Faculty Starter Grant in Value Assessment-Health Outcomes Research (VA-HOR) offers financial support to individuals beginning independent research careers in VA HOR at the faculty level at an accredited U.S. university.
Program Goals
The PhRMA Foundation seeks research proposals that investigate challenges and potential solutions related to evaluating the delivery, safe use, effectiveness, and value (clinical, patient-centered, and economic) of medicines and other health care interventions. Proposals could be empirical analyses or studies addressing methodological aspects of the following areas:

• Clinical and economic outcomes using real-world data and analytic tools
• Clinical outcomes assessments
• Patient-reported and/or patient-centered outcomes, especially for diverse or underserved populations
• Patient health preferences research
• Evaluation and outcomes assessments focused on health equity or unmet need

Innovative methods for measuring and reporting novel value elements (e.g., clinical, cost, health preference) from different stakeholder perspectives, especially patientsDevelopment of innovative decision and communication tools
Health policy research
Proposals should incorporate patient engagement at an appropriate level to be responsive.
Funding
The PhRMA Foundation Faculty Starter Grant in Value Assessment-Health Outcomes Research provides funding of $100,000 for one year. Funding is conditional upon the awardee’s continued employment with the university, which will be assessed on a quarterly basis prior to payment. Awardees are required to notify the PhRMA Foundation if they leave the university. Payments will be made directly to the university on behalf of the awardee, with the understanding the university will administer the funds.

Eligibility

Applicants (U.S. and non-U.S. citizens) must be full-time, promotion-eligible, research-intensive faculty at a doctoral degree-granting accredited U.S. university at the time of application submission.Applicants must be within the first five years of independent status.Applicants must be eligible to apply for independent external research funding by their university.Applicants should not have other substantial sources of research funding. Individuals receiving only intramural funding or start-up funding from their university are eligible to apply. Use of FundsFunds may be budgeted to include salary support for the awardee but should not exceed 25% of the budget.Funds may be budgeted to include the support of a technician, graduate student, or postdoctoral fellow at an hourly rate.Up to $1,500 may be used for travel by the awardee to professional meetings in the United States.Funds may be used to purchase equipment and/or data to support the research efforts.

Ineligibility

If multiple applicants are submitting proposed efforts on the same project, the efforts must be separate activities and not duplicative. Funds may not be used to provide fringe benefits or indirect costs.The funds may not be used to provide tuition, fringe benefits, or indirect costs for personnel (technician, graduate student, or postdoctoral fellow). Said personnel may not be an active award recipient of the PhRMA Foundation.